To verify this hypothesis, in the present study we examined the specific effect of TNFα on the promotion of tamoxifen sensitivity in ERα-positive breast cancer and identified NCOR1 as a key regulator acting downstream of TNFα. Here, NCOR1 is linked to breast carcinoma.